36 related articles for article (PubMed ID: 9061068)
1. The oncological outcomes of isolated limb perfusion and neo-adjuvant radiotherapy in soft tissue sarcoma patients - A nationwide multicenter study.
van Praag VM; Fiocco M; Bleckman RF; van Houdt WJ; Haas RLM; Verhoef C; Grunhagen DJ; van Ginkel RJ; Bonenkamp JJ; van de Sande MAJ
Eur J Surg Oncol; 2023 Feb; 49(2):339-344. PubMed ID: 36085118
[TBL] [Abstract][Full Text] [Related]
2. Decreased response rates by the combination of histamine and IL-2 in melphalan-based isolated limb perfusion.
Brunstein F; Hoving S; aan de Wiel-Ambagtsheer G; de Bruijn EA; Guetens G; Eggermont AM; ten Hagen TL
Cancer Immunol Immunother; 2007 Apr; 56(4):573-80. PubMed ID: 16896966
[TBL] [Abstract][Full Text] [Related]
3. The Use of Regional Anesthesia to Reduce Blood Loss in Isolated Limb Perfusion (ILP)-A Novel Approach.
Niethard M; Fischer H; Gaßmann B; Haralambiev L; Tipp A; Tunn PU
J Clin Med; 2023 Oct; 12(20):. PubMed ID: 37892681
[TBL] [Abstract][Full Text] [Related]
4. Do Tumor SURVIVIN and MDM2 Expression Levels Correlate with Treatment Response and Clinical Outcome in Isolated Limb Perfusion for In-Transit Cutaneous Melanoma Metastases?
Russano F; Del Fiore P; Cassalia F; Benna C; Dall'Olmo L; Rastrelli M; Mocellin S
J Pers Med; 2023 Nov; 13(12):. PubMed ID: 38138884
[TBL] [Abstract][Full Text] [Related]
5. Proton Irradiation with Hyperthermia in Unresectable Soft Tissue Sarcoma.
Datta NR; Schneider R; Puric E; Ahlhelm FJ; Marder D; Bodis S; Weber DC
Int J Part Ther; 2016; 3(2):327-336. PubMed ID: 31772984
[TBL] [Abstract][Full Text] [Related]
6. Isolated limb perfusion with melphalan and TNF-alpha in the treatment of extremity sarcoma.
Verhoef C; de Wilt JH; Grünhagen DJ; van Geel AN; ten Hagen TL; Eggermont AM
Curr Treat Options Oncol; 2007 Dec; 8(6):417-27. PubMed ID: 18066703
[TBL] [Abstract][Full Text] [Related]
7. Role of isolated limb perfusion with recombinant human tumor necrosis factor α and melphalan in locally advanced extremity soft tissue sarcoma.
Jakob J; Hohenberger P
Cancer; 2016 Sep; 122(17):2624-32. PubMed ID: 27197621
[TBL] [Abstract][Full Text] [Related]
8. Isolated limb perfusion with TNF-alpha and melphalan in locally advanced soft tissue sarcomas of the extremities.
Grünhagen DJ; de Wilt JH; van Geel AN; Verhoef C; Eggermont AM
Recent Results Cancer Res; 2009; 179():257-70. PubMed ID: 19230545
[TBL] [Abstract][Full Text] [Related]
9. High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma.
Lienard D; Ewalenko P; Delmotte JJ; Renard N; Lejeune FJ
J Clin Oncol; 1992 Jan; 10(1):52-60. PubMed ID: 1727926
[TBL] [Abstract][Full Text] [Related]
10. High dose tumor necrosis factor-alpha and melphalan administered via isolated limb perfusion for advanced limb soft tissue sarcoma results in a >90% response rate and limb preservation.
Gutman M; Inbar M; Lev-Shlush D; Abu-Abid S; Mozes M; Chaitchik S; Meller I; Klausner JM
Cancer; 1997 Mar; 79(6):1129-37. PubMed ID: 9070490
[TBL] [Abstract][Full Text] [Related]
11. Isolated limb reperfusion with tumor necrosis factor and melphalan in patients with extremity melanoma after failure of isolated limb perfusion with chemotherapeutics.
Bartlett DL; Ma G; Alexander HR; Libutti SK; Fraker DL
Cancer; 1997 Dec; 80(11):2084-90. PubMed ID: 9392330
[TBL] [Abstract][Full Text] [Related]
12. Isolated limb perfusion with tumor necrosis factor-alpha and melphalan for patients with unresectable soft tissue sarcoma of the extremities.
Noorda EM; Vrouenraets BC; Nieweg OE; van Coevorden F; van Slooten GW; Kroon BB
Cancer; 2003 Oct; 98(7):1483-90. PubMed ID: 14508836
[TBL] [Abstract][Full Text] [Related]
13. Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience.
Eggermont AM; Schraffordt Koops H; Klausner JM; Kroon BB; Schlag PM; Liénard D; van Geel AN; Hoekstra HJ; Meller I; Nieweg OE; Kettelhack C; Ben-Ari G; Pector JC; Lejeune FJ
Ann Surg; 1996 Dec; 224(6):756-64; discussion 764-5. PubMed ID: 8968230
[TBL] [Abstract][Full Text] [Related]
14. Treatment of recurrent sarcoma of the extremities by isolated limb perfusion using tumor necrosis factor alpha and melphalan.
Santinami M; Deraco M; Azzarelli A; Cascinelli F; Chiti A; Costagli V; Inglese MG; Manzi R; Quagliolo V; Rebuffoni G; Santoro N; Vaglini M
Tumori; 1996; 82(6):579-84. PubMed ID: 9061068
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]